Middle East & Africa Overactive Bladder Treatment Market : Table of Contents

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Middle East & Africa Overactive Bladder Treatment Market– By Pharmacotherapy

1.3.2 Middle East & Africa Overactive Bladder Treatment Market– By Disease Type

1.3.3 Middle East & Africa Overactive Bladder Treatment Market – By Country

2. Middle East & Africa Overactive Bladder Treatment Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East & Africa Overactive Bladder Treatment Market – Market Landscape

4.1 Overview

4.2 Middle East & Africa PEST Analysis

4.3 Expert Opinion

5. Middle East & Africa Overactive Bladder Treatment Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Prevalence of Urinary Incontinence

5.1.2 Growing Incidence of Urinary Tract Infections

5.2 Key Market Restraints

5.2.1 Recalls of Therapeutic Drugs

5.3 Key Market Opportunities

5.3.1 Increasing Number of Mergers and Acquisitions

5.4 Future Trends

5.4.1 Robust Pipeline of Drugs and Successive Launch of Novel Therapies

5.5 Impact analysis

6. Middle East & Africa Overactive Bladder Treatment Market – Middle East & Africa Analysis

6.1 Middle East & Africa Overactive Bladder Treatment Market Revenue Forecast and Analysis

7. Middle East & Africa Overactive Bladder Treatment Market Analysis and Forecasts To 2028 – By Pharmacotherapy

7.1 Overview

7.2 Middle East & Africa Overactive Bladder Treatment Market, By Pharmacotherapy 2021 & 2028 (%)

7.3 Mirabegron

7.3.1 Overview

7.3.2 Mirabegron: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.4 Botox

7.4.1 Overview

7.4.2 Botox: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.5 Neurostimulation

7.5.1 Overview

7.5.2 Neurostimulation: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.3 Transcutaneous Sacral Nerve Stimulation

7.5.3.1 Overview

7.5.3.2 Transcutaneous Sacral Nerve Stimulation: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.4 Transcutaneous Tibial Nerve Stimulation

7.5.4.1 Overview

7.5.4.2 Transcutaneous Tibial Nerve Stimulation: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.5 Percutaneous Posterior Tibial Nerve Stimulation

7.5.5.1 Overview

7.5.5.2 Percutaneous Posterior Tibial Nerve Stimulation: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.5.6 Others

7.5.6.1 Overview

7.5.6.2 Others: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

7.6 Anticholinergics

7.6.1 Overview

7.6.2 Anticholinergics: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.3 Solifenacin

7.6.3.1 Overview

7.6.3.2 Solifenacin: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.4 Oxybutynin

7.6.4.1 Overview

7.6.4.2 Oxybutynin: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.5 Fesoterodine

7.6.5.1 Overview

7.6.5.2 Fesoterodine: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.6 Darifenacin

7.6.6.1 Overview

7.6.6.2 Darifenacin: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.7 Tolterodine

7.6.7.1 Overview

7.6.7.2 Tolterodine: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.8 Trospium

7.6.8.1 Overview

7.6.8.2 Trospium: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.6.9 Other Anticholinergics

7.6.9.1 Overview

7.6.9.2 Other Anticholinergics: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Million)

7.7 Intravesical Instillation

7.7.1 Overview

7.7.2 Intravesical Instillation: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

8. Middle East & Africa Overactive Bladder Treatment Market Analysis and Forecasts To 2028 – By Disease Type

8.1 Overview

8.2 Middle East & Africa Overactive Bladder Treatment Market, By Disease Type 2021 & 2028 (%)

8.3 Idiopathic Overactive Bladder

8.3.1 Overview

8.3.2 Idiopathic: Middle East & Africa Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Neurogenic Overactive Bladder

8.4.1 Overview

8.4.2 Neurogenic: Overactive Bladder Market Revenue and Forecast to 2028 (US$ Mn)

9. Overactive Bladder Treatment Market Revenue and Forecasts to 2028 – Country Analysis

9.1 Overview

9.1.1 Middle East & Africa: Overactive Bladder Treatment Market, by Country, 2021 & 2028 (%)

9.1.1.1 UAE: overactive bladder treatment Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.1.1 UAE: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.2 UAE: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)

9.1.1.1.2.1 UAE: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.1.1.1.2.2 UAE Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.1.1.1.3 UAE: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)

9.1.1.2 Saudi Arabia: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.1 Saudi Arabia: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.2 Saudi Arabia: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)

9.1.1.2.2.1 Saudi Arabia: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.1.1.2.2.2 Saudi Arabia Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.1.1.2.3 Saudi Arabia: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)

9.1.1.3 South Africa: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.3.1 South Africa: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.2 South Africa: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)

9.1.1.3.2.1 South Africa: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.1.1.3.2.2 South Africa Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.1.1.3.3 South Africa: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)

9.1.1.4 Rest of Middle East & Africa: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.4.1 Rest of Middle East & Africa: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.4.2 Rest of Middle East & Africa: Overactive Bladder Treatment Market, by Pharmacotherapy, 2019–2028 (US$ Million)

9.1.1.4.2.1 Rest of Middle East & Africa: Overactive Bladder Treatment Market, by Anticholinergic, 2019–2028 (US$ Million)

9.1.1.4.2.2 Rest of Middle East & Africa Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (USD Million)

9.1.1.4.3 Rest of Middle East & Africa: Overactive Bladder Treatment Market, by Disease Type, 2019–2028 (US$ Million)

10. Overactive Bladder Treatment Market– Industry Landscape

10.1 Overview

10.2 Organic Developments

10.2.1 Overview

11. Company Profiles

11.1 Alembic Pharmaceuticals Limited

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Astellas Pharma Inc

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 AbbVie Inc

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Teva Pharmaceutical Industries Ltd

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Endo Pharmaceuticals Inc.

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Hisamitsu Pharmaceutical Co.,Inc.

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Medtronic Plc

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Pfizer Inc

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary of Terms

LIST OF TABLES

Table 1. UAE Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 2. UAE Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 3. UAE Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 4. UAE Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 5. Saudi Arabia Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 6. Saudi Arabia Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 7. Saudi Arabia Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 8. Saudi Arabia Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 9. South Africa Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 10. South Africa Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 11. South Africa Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 12. South Africa Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 13. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Pharmacotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 14. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Anticholinergic – Revenue and Forecast to 2028 (US$ Million)

Table 15. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Neurostimulation – Revenue and Forecast to 2028 (US$ Million)

Table 16. Rest of Middle East & Africa Overactive Bladder Treatment Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)

Table 17. Organic Developments Done by Companies

Table 18. Glossary of Terms

LIST OF FIGURES

Figure 1. Middle East & Africa Overactive Bladder Treatment Market Segmentation

Figure 2. Middle East & Africa Overactive Bladder Treatment Market Segmentation, By Country

Figure 3. Middle East & Africa Overactive Bladder Treatment Market Overview

Figure 4. Mirabegron Segment Held Largest Share by Pharmacotherapy in Middle East & Africa Overactive Bladder Treatment market

Figure 5. South Africa Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Middle East & Africa: PEST Analysis

Figure 7. Middle East & Africa Overactive Bladder Treatment Market: Impact Analysis of Driver and Restraints

Figure 8. Middle East & Africa Overactive Bladder Treatment Market – Revenue Forecast and Analysis – 2019- 2028

Figure 9. Middle East & Africa Overactive Bladder Treatment Market, by Pharmacotherapy 2021 & 2028 (%)

Figure 10. Mirabegron: Middle East & Africa Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 11. Botox: Middle East & Africa Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. Neurostimulation: Middle East & Africa Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13. Transcutaneous Sacral Nerve Stimulation: Middle East & Africa Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. Transcutaneous Tibial Nerve Stimulation: Middle East & Africa Overactive Bladder Market Revenue and Forecasts to 2028 (US$ MN)

Figure 15. Percutaneous Posterior Tibial Nerve: Middle East & Africa Overactive Bladder Stimulation Market Revenue and Forecasts To 2028 (US$ MN)

Figure 16. Others: Middle East & Africa Overactive Bladder Market Revenue and Forecasts To 2028 (US$ MN)

Figure 17. Anticholinergics: Middle East & Africa Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. Solifenacin: Middle East & Africa Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Oxybutynin: Middle East & Africa Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20. Fesoterodine: Middle East & Africa Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Darifenacin: Middle East & Africa Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. Tolterodine: Middle East & Africa Overactive Bladder Market Revenue and Forecasts To 2028 (US$ Million)

Figure 23. Trospium: Middle East & Africa Overactive Bladder Market Revenue and Forecasts To 2028 (US$ Million)

Figure 24. Other Anticholinergics: Middle East & Africa Overactive Bladder Market Revenue and Forecasts To 2028 (US$ Million)

Figure 25. Intravesical Instillation: Middle East & Africa Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26. Middle East & Africa Overactive Bladder Treatment Market, by Disease Type 2021 & 2028 (%)

Figure 27. Idiopathic: Middle East & AfricaOveractive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28. Neurogenic: Overactive Bladder Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29. Middle East & Africa: Overactive Bladder Treatment Market, by Key Country – Revenue (2021) (US$ Million)

Figure 30. UAE: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31. Saudi Arabia: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32. South Africa: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33. Rest of Middle East & Africa: Overactive Bladder Treatment Market – Revenue and Forecast to 2028 (US$ Million)